TNF and cryptococcosis: Furthermore, the enhanced risks for cryptococcal infection in individuals undergoing anti-TNF-α therapies for sepsis, cancer, and autoimmune disorders provided strong evidence that this cytokine also plays an important role in mediating host defense against C. neoformans infection in human (18–20).